Zika Virus Vaccine Candidate
mRNA-based or DNA vaccine platform for Zika flavivirus prevention, in clinical stages. Fits HTS 3002.49.0050 as other virus culture-derived prophylactic product via biotech processes.
Import Duty Rates by Country of Origin
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If other specific viral like COVID
Enumerated viruses have subheadings; unlisted to other.
If diagnostic PCR kits from cultures
Test kits with cultures as reagents under 3822.
If integrated into medical device
Device-embedded vaccines to Chapter 90 instruments.
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Classify as gene therapy if applicable; special USDA permits for vectors
• Document trial phase and IRB approval; frozen shipment standard
Related Products under HTS 3002.49.00.50
Malaria RTS,S Vaccine
Recombinant circumsporozoite protein-based vaccine with AS01 adjuvant for Plasmodium falciparum. HTS 3002.49.0050 as other protozoal culture-derived prophylactic.
Human Papillomavirus Recombinant Vaccine
VLP vaccine from HPV L1 protein expression for cervical cancer prevention. Classified HTS 3002.49.0050 as other viral biotechnological product.
Human Rotavirus Vaccine
A live attenuated oral vaccine containing reassortant rotaviruses for active immunization against rotavirus gastroenteritis in infants. Classified under HTS 3002.49.0050 as it is a vaccine for human use, other than those specifically enumerated elsewhere in heading 3002. It is prepared for prophylactic purposes via biotechnological processes.
Dengue Tetravalent Vaccine
A chimeric live-attenuated tetravalent vaccine protecting against all four dengue virus serotypes for endemic prevention. Falls under HTS 3002.49.0050 as an 'other' vaccine for human prophylactic use, not matching specific viral listings. Developed through biotechnological recombination.
Cholera Oral Vaccine
Inactivated oral vaccine with recombinant B-subunit and killed whole cells for cholera prevention in travelers. HTS 3002.49.0050 applies as an 'other' microbial culture-based vaccine for prophylactic human use. Not yeast-derived, fitting chapter exclusions.
Shigella Conjugate Vaccine
Polysaccharide-protein conjugate vaccine targeting Shigella flexneri for diarrheal disease prophylaxis. Classified in HTS 3002.49.0050 as other immunological product from microbial cultures, modified biotechnologically for therapeutic use.